Meeder Asset Management Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 3,405 shares of ARWR stock, worth $63,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,405

Previous 3,405 -0.0%

Holding current value

$63,128

Previous $88,000 26.14%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$21.87 - $28.24 $72,892 - $94,123	3,333 Added 4629.17%	3,405 $88,000
Q1 2024 May 07, 2024	BUY	$27.21 - $39.48 $1,959 - $2,842	72 New	72 $2,000
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $3,318 - $5,410	112 Added 19.31%	692 $23,000
Q2 2022 Aug 08, 2022	BUY	$27.79 - $50.61 $7,531 - $13,715	271 Added 87.7%	580 $20,000
Q1 2022 May 10, 2022	BUY	$39.62 - $69.97 $12,242 - $21,620	309 New	309 $14,000
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $218,418 - $310,237	-3,760 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$58.38 - $84.96 $93,758 - $136,445	-1,606 Reduced 29.93%	3,760 $235,000
Q2 2021 Aug 09, 2021	BUY	$62.15 - $90.32 $72,839 - $105,855	1,172 Added 27.94%	5,366 $444,000
Q1 2021 Apr 28, 2021	BUY	$61.35 - $90.47 $254,479 - $375,269	4,148 Added 9017.39%	4,194 $278,000
Q4 2020 Feb 09, 2021	SELL	$43.82 - $85.37 $140,048 - $272,842	-3,196 Reduced 98.58%	46 $4,000
Q3 2020 Nov 02, 2020	BUY	$33.21 - $51.27 $14,147 - $21,841	426 Added 15.13%	3,242 $140,000
Q2 2020 Aug 11, 2020	BUY	$26.12 - $43.27 $27,974 - $46,342	1,071 Added 61.38%	2,816 $121,000
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $25,823 - $79,278	-1,256 Reduced 41.85%	1,745 $48,000
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $73,698 - $191,213	-2,619 Reduced 46.6%	3,001 $190,000
Q3 2019 Oct 17, 2019	SELL	$26.26 - $34.86 $79,068 - $104,963	-3,011 Reduced 34.89%	5,620 $157,000
Q2 2019 Aug 05, 2019	BUY	$17.43 - $28.82 $61,632 - $101,907	3,536 Added 69.4%	8,631 $228,000
Q1 2019 Apr 16, 2019	SELL	$12.05 - $20.18 $21,846 - $36,586	-1,813 Reduced 26.24%	5,095 $94,000
Q4 2018 Jan 17, 2019	BUY	$10.74 - $19.7 $1,417 - $2,600	132 Added 1.95%	6,908 $87,000
Q3 2018 Nov 02, 2018	BUY	$14.0 - $20.3 $94,864 - $137,552	6,776 New	6,776 $0
Q4 2017 Feb 02, 2018	SELL	$3.14 - $4.5 $4,138 - $5,931	-1,318 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$1.69 - $4.33 $2,227 - $5,706	1,318	1,318 $6,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Arrowhead Pharmaceuticals, Inc. Transaction History